The effect of Liposomal Bupivacaine on the quality of recovery in patients undergoing shoulder arthroscopy
Enrolling By Invitation
18 years - 99 years
All
Phase
3
200 participants needed
1 Location
Brief description of study
The research study is being conducted to see if using liposomal bupivacaine for the interscalene block will improve the patient pain control and the whole patient’s experience 48 hours after surgery when compared to using the regular Marcaine in
addition to the dexamethasone.
Detailed description of study
You are being invited to participate in a research study because you will be having shoulder arthroscopy (called shoulder scope) and you will receive a nerve block to numb your shoulder and arm as part of your pain control protocol after surgery.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: shoulder
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 832346
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
